Determining the Vasohibin-1 Levels of the Serum and Broncoalveolar Lavage Fluid in the Patients with Lung Cancer

Ozkaya A. L., KELEŞ M. S., LALOĞLU E., YILMAZEL UÇAR E., YILMAZ S.

KONURALP TIP DERGISI, cilt.14, sa.2, ss.298-303, 2022 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.18521/ktd.1066032
  • Dergi Adı: KONURALP TIP DERGISI
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.298-303
  • Anahtar Kelimeler: Angiogenesis, Broncoalveolar Lavage Fluid, Lung Cancer, Metastasis, Vasohibin-1, NEGATIVE FEEDBACK REGULATOR, PROGNOSTIC-SIGNIFICANCE, EXPRESSION, ANGIOGENESIS, ENDOTHELIUM, CARCINOMA, PREDICTOR, SURVIVAL
  • Atatürk Üniversitesi Adresli: Evet

Özet

Objective: Lung cancer constitutes 17% of all cancer cases and accounts for 23% of the deaths caused by cancer all over the world. Vasohibin-1 (VASH-1) is an angiogenesis-inhibiting factor synthesized by endothelial cells (ECs). This study aimed to examine the VASH-1 levels of the bronchoalveolar lavage (BAL) and serum in the patients with lung cancer.